TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06378411

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Music Game Intervention
Description: Use of music to induce improvements in cognitive and motor outcomes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Music Game Intervention
Description: Use of music to induce improvements in cognitive and motor outcomes.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Music Game Intervention
Description: Use of music to induce improvements in cognitive and motor outcomes.
Study: NCT05326113

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: After POEM, patient underwent physiotherapy consisting of diaphragmatic breathing and dynamic stabilization exercises and PPIs

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: All patients will be treated with standard course of PPIs after POEM without physiotherapy.
Study: NCT04633174

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sous Vide Device (SVD)
Description: A basin will be filled to the marked line with water from jugs at room temperature, for each frozen extremity. The sous vide device (SVD) will be attached to the distal edge of the basin. The SVD will be turned on and set to maintain the bath at a constant 38 degrees celsius for 30 minutes duration. The thermometers will be powered on continuously and the researcher will record temperatures simultaneously from each thermometer every 2 minutes. At the end of the 30 minute treatment, the SVD will be powered off and the extremity assessed by the researcher for warmth and pliability. If the extremity still feels cold or frozen, an additional 30 minutes in the water bath will commence, with subsequent reassessment. Rewarming will be considered complete when the affected tissue becomes red or purple, soft, and pliable.
Study: NCT05805566

Intervention type: OTHER
Intervention: Blood collection
Description: Blood samples will be collected from the patient at baseline. This blood will be collected during the standard of care blood drawing in extra.
Study: NCT05843682

Intervention type: DEVICE
Group type: OTHER
Intervention: Using the Avatr App
Description: The patients will use the mobile application called Avatr, which will monitor their health data, as well as provide individualized care and early intervention through alerts generated for the multidisciplinary team.
Study: NCT06314776

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual physiotherapy without Whole-Body Vibration
Description: Manual Therapy, passive and active mobilizations, stretching, respiratory techniques

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pre-Usual physiotherapy
Description: (GMFM, Test 10M, Test Time Up and Go)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Post-Usual physiotherapy
Description: (GMFM, Test 10M, Test Time Up and Go)
Study: NCT06159855

Intervention type: OTHER
Group type: OTHER
Intervention: Intervention group: nurse-led education for bowel preparation of colonoscopy
Description: 1. PRE-TEST~   a) Patients will be evaluated using the Patient Information Survey, Procedure Compliance Survey and Beck Anxiety Scale.~2. INTERVENTION~   1. Patients will be given face-to-face training in the clinic training room of the unit.~  2. After face-to-face training is given, an educational brochure will be given to the patient.~  3. If the patient is constipated, the bowel preparation diet is requested to be started 5 days in advance. If the patient is not constipated, the bowel preparation diet is started 3 days in advance.~  4. After the intervention group is given bowel preparation training, reminders about colonoscopy will be made via instant messaging 3 to 5 days before the day of the colonoscopy.~3. LAST TEST~   1. Data will be collected again using the Patient Information Survey, Procedure Compliance Survey and Beck Anxiety Scale.~  2. The cleanliness of the intestines will be evaluated by the physician using the Ottawa Bowel Preparation Scale.
Study: NCT06227403

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Leadership, Engagement, and youth Activism Program with Mindfulness
Description: The Leadership, Engagement, and youth Activism Program with Mindfulness intervention (LEAP-M) was designed and co-created with youth to improve youth wellbeing by enhancing civic engagement and leadership opportunities and by developing mindfulness in day-to-day life. LEAP-M seeks to foster these improvements in youth of color as a strategy to combat structural racism encountered at school- and neighborhood-levels and to increase youth mental, emotional, and behavioral health. Youth voice is incorporated into the intervention, with facilitators leading the first 7 sessions, and youth leading the remainder.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: EnvisionIT
Description: Participants in this arm will receive 14 sessions of EnvisionIT training, focused on preparing students with essential transition skills and digital literacy through competency in information technology, financial literacy, English language arts skills, and college and career readiness. All sessions will be delivered by facilitators trained in EnvisionIT.
Study: NCT06611111

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ceftriaxone (Rocephin®)
Description: Slightly yellow liquid.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dextrose 5% (D5W)
Description: Colorless liquid
Study: NCT06616272

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cervical rehabilitation
Description: * Manual joint mobilization (Grades I-V) of painful and restricted cervical spine segments.~* Supine manual cervical traction to stretch and mobilize the cervical spinal tissues.~* Manual soft tissue mobilization of the cervical, upper thoracic and/or shoulder muscles.~* Passive stretching of hypertonic muscles and active strengthening of hypotonic muscles.~* Motor-control and isometric exercises to activate the deep neck flexors.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cervical rehabilitation
Description: * Manual joint mobilization (Grades I-V) of painful and restricted cervical spine segments.~* Supine manual cervical traction to stretch and mobilize the cervical spinal tissues.~* Manual soft tissue mobilization of the cervical, upper thoracic and/or shoulder muscles.~* Passive stretching of hypertonic muscles and active strengthening of hypotonic muscles.~* Motor-control and isometric exercises to activate the deep neck flexors.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Concussion Care
Description: Standard Concussion Care interventions are individualized to each patient and their adjudicated profile(s)/moderating factor(s) and may include any/all of the following:~* Behavioral regulation~* Vestibular rehabilitation~* Oculomotor rehabilitation~* Exertion rehabilitation~* Pharmacological management~* Behavioral sleep intervention~* \*Cervical spine rehabilitation (the variable of interest in this study)~* Psychotherapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Concussion Care
Description: Standard Concussion Care interventions are individualized to each patient and their adjudicated profile(s)/moderating factor(s) and may include any/all of the following:~* Behavioral regulation~* Vestibular rehabilitation~* Oculomotor rehabilitation~* Exertion rehabilitation~* Pharmacological management~* Behavioral sleep intervention~* \*Cervical spine rehabilitation (the variable of interest in this study)~* Psychotherapy
Study: NCT05120856

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AAT-App
Description: Participants will receive the active AAT-App on their smartphone, which includes ApBM training, and prompted to engage with the app during the 28-day intervention period.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Minimal AAT-App
Description: Participants will receive the minimal version of AAT-App, which does not include ApBM training, on their smartphone and prompted to engage with the app during the 28-day intervention period.
Study: NCT06708520

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rupatadine
Description: 10 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rupatadine
Description: 10 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rupatadine
Description: 10 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rupatadine
Description: 10 mg tablets
Study: NCT06704620

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Description: Diphenhydramine intramuscular injection 20mg qd d0-2 Q3W

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab intravenous infusion 200mg d1

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab
Description: Tislelizumab intravenous infusion 200mg d1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed intravenous infusion 500mg/m2 d1

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed intravenous infusion 500mg/m2 d1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin paclitaxel
Description: Albumin paclitaxel intravenous infusion 260mg/m2 d1

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Albumin paclitaxel
Description: Albumin paclitaxel intravenous infusion 260mg/m2 d1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin intravenous infusion AUC5 d1

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin intravenous infusion AUC5 d1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin intravenous infusion 75mg/m2 d1

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Cisplatin intravenous infusion 75mg/m2 d1
Study: NCT06725147

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AI enabled wellness chatbot
Description: Elomia uses generative AI to respond to user input about psychological stress and distress. It was trained on the responses of real therapists with expertise in cognitive-behavioral therapy. It provides an array of wellness interventions including exercises for calming; • exercises for falling asleep; • grounding techniques; • exercises to reduce anxiety; • breathing exercises; • exercises to improve self-esteem.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Penn Digital Wellness Resources
Description: This active control intervention consists of a variety of digital wellness and stress management resources that are freely available to all Penn students.
Study: NCT06723418

Intervention type: OTHER
Intervention: Malnutriton Screening Tool (PYMS)
Description: In a pilot implementation study, PYMS will be used on children with IBD attending the outpatient and inpatient hospital clinics
Study: NCT06735092

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise-Only Group (Control Group)
Description: Participants in this group will only undergo a standardized exercise protocol. The exercises will be part of a program lasting 6 weeks, conducted 2 days per week. A combined evidence-based exercise program consisting of wrist isometric, concentric, and eccentric exercises will be applied to the individuals in the group. For free-weight exercises, participants will start with weights of 0.5-1 kg, tailored to the individual. Progression will be achieved with 0.5-1 kg increments. For exercises using resistance bands, the increase in resistance will be provided by selecting the next level band color. Participants will be assessed before treatment, at the end of the 6th week, and at the end of the 12th week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise + Forearm Counterforce Brace Group
Description: Participants in this group will undergo a standardized exercise protocol and will be provided with a counterforce forearm brace in addition to exercise therapy. The exercises will be part of a program lasting 6 weeks, conducted 2 days per week. A combined evidence-based exercise program consisting of wrist isometric, concentric, and eccentric exercises will be applied to the individuals in the group. For free-weight exercises, participants will start with weights of 0.5-1 kg, tailored to the individual. Progression will be achieved with 0.5-1 kg increments. For exercises using resistance bands, the increase in resistance will be provided by selecting the next level band color. Participants will be assessed before treatment, at the end of the 6th week, and at the end of the 12th week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise + Wrist Brace Group
Description: Participants in this group will undergo a standardized exercise protocol and will be provided with a wrist brace in addition to exercise therapy. The exercises will be part of a program lasting 6 weeks, conducted 2 days per week. A combined evidence-based exercise program consisting of wrist isometric, concentric, and eccentric exercises will be applied to the individuals in the group. For free-weight exercises, participants will start with weights of 0.5-1 kg, tailored to the individual. Progression will be achieved with 0.5-1 kg increments. For exercises using resistance bands, the increase in resistance will be provided by selecting the next level band color. Participants will be assessed before treatment, at the end of the 6th week, and at the end of the 12th week.
Study: NCT06736028

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet Therapy
Description: Participants will be provided food to meet the ketogenic diet prescription for the 4-week weight maintenance phase.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Calorie Restriction
Description: Participants will follow a commercial low-energy diet and be provided with meal replacements for 4 weeks aiming to achieve a minimum of 5% weight loss.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Calorie Restriction
Description: Participants will follow a commercial low-energy diet and be provided with meal replacements for 4 weeks aiming to achieve a minimum of 5% weight loss.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Support
Description: Participants will meet weekly with a registered dietitian, for a 20-minute consultation throughout the entire study period (10 weeks) to increase engagement and improve adherence and retention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Support
Description: Participants will meet weekly with a registered dietitian, for a 20-minute consultation throughout the entire study period (10 weeks) to increase engagement and improve adherence and retention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet Therapy
Description: Participants will have food provided to meet the standard low-fat diet prescription for the 4-week weight maintenance phase.
Study: NCT06734585

Intervention type: DRUG
Intervention: Gilteritinib
Description: tablet, oral
Study: NCT06735677

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sexual health education
Description: These sessions covered reproductive health, sexual activity during pregnancy and the postpartum period, personal and sexual hygiene, domestic violence during pregnancy, and misconceptions about pregnancy.
Study: NCT06735560

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 89Zr-TLX250 PET/CT
Description: Patients will receive 89Zr-TLX250 for detection of CAIX-expressing tumor by PET imaging.
Study: NCT06735066

Intervention type: PROCEDURE
Intervention: Ascending urethrocystography
Description: It will be performed after instructing the patient to evacuate the bladder. A contrast agent will be infused through the urethra under fluoroscopy, using a urethral catheter or Knutson's clamp at the external urethral meatus. When the bladder is full, an anteroposterior film and two oblique films will be taken. Voiding cystourethrography will be performed as a part of this imaging examination. From this procedure, the following findings may be diagnosed:~* Upper urinary tract: Vesicoureteral reflux (VUR); laterality and degrees of VUR will be defined.~* Bladder: Capacity (defunctionalized, Small-sized or contracted bladder), neurogenic bladder, bladder diverticulum, filling defects, etc.~* Urethra: Stricture and filling defects.
Study: NCT06734299

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunscreen A
Description: Sunscreen A will be applied to both lower legs (between the knee and ankle) and then her full face to the randomly assigned participants at Visit1, Visit 2, and Visit 3.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunscreen B
Description: Sunscreen B will be applied to both lower legs (between the knee and ankle) and then her full face to the randomly assigned participants at Visit1, Visit 2, and Visit 3.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sunscreen C
Description: Sunscreen C will be applied to both lower legs (between the knee and ankle) and then her full face to the randomly assigned participants at Visit1, Visit 2, and Visit 3.
Study: NCT06734754

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fetal heart sound listening
Description: The pregnant women in the experimental group and their partners listened to fetal heart sounds for 7 days. After obtaining pre-test data from the participants in the intervention group, the midwifery intervention to be implemented was explained. A fetal heart rate monitoring device, which will be given to couples to listen to the fetal heart sound before sleep, was introduced. They were told that they had to listen to the fetal heart sound at least 7 times using this device. A supporting application was downloaded to the pregnant woman's phone for the installation of the fetal heart rate monitoring device. The way of using the application and the operation steps were introduced. It was explained to the couples that the application can detect the baby's heartbeat within seconds thanks to its smart search technology, and also provides step-by-step guidance by giving live feedback.
Study: NCT06734845

Intervention type: PROCEDURE
Intervention: Total Knee Arthroplasty
Description: Total Joint (Knee or Hip) Arthroplasty

Intervention type: PROCEDURE
Intervention: Total Joint Arthroplasty
Description: Participants will be patients undergoing first total knee or total hip replacement
Study: NCT06735222

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol acetate (HT-Ac)
Description: Hydroxytyrosol acetate (15 mg) orally co-administered with 2 g EPA

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol acetate (HT-Ac)
Description: Hydroxytyrosol acetate (15 mg) orally co-administered with 2 g EPA

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol acetate (HT-Ac)
Description: Hydroxytyrosol acetate (15 mg) orally co-administered with 2 g EPA

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol eicosapentanoate (HT-EPA)
Description: Oral intake of hydroxytyrosol eicosapentanoate (15 mg) solubilized in an EPA-enriched oil matrix.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol eicosapentanoate (HT-EPA)
Description: Oral intake of hydroxytyrosol eicosapentanoate (15 mg) solubilized in an EPA-enriched oil matrix.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol eicosapentanoate (HT-EPA)
Description: Oral intake of hydroxytyrosol eicosapentanoate (15 mg) solubilized in an EPA-enriched oil matrix.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oleacore®
Description: Oleacore® (containing 15 mg of hydroxytyrosol) orally co-administered with 2 g EPA

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oleacore®
Description: Oleacore® (containing 15 mg of hydroxytyrosol) orally co-administered with 2 g EPA

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oleacore®
Description: Oleacore® (containing 15 mg of hydroxytyrosol) orally co-administered with 2 g EPA
Study: NCT06734286

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CogMed
Description: CogMed which is a computerized working memory training program developed by Karolinska University.
Study: NCT06736080

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MUNC-CD34
Description: * Dosage: ≥ 2 x10e6 CD34/kg after thawing, dose limit: 20x10e6 CD34+ cells/kg~* Route of administration: intravenous, on D0

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MUNC-T3
Description: * Dosage: \[1.10e4; 5.10e6\] T-CD3+/kg after thawing,~* Route of administration: intravenous, on D14 post-GT +/- D28 In case of persistent circulating T-cell after the HLH remission at inclusion, the MUNC-CD34 will be completed by MUNC-T3 infusion
Study: NCT06735807

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Generated AI-based intervention (Emohaa)
Description: Participants will complete the intervention process by interacting with the Wechat applet. Participants will be required to complete a 6-week self-help therapy. Participants will be required to have a 30-minute dialogue including input and reflection time with Emohaa each week simultaneously with group ACT. Participants are free to dialogue with Emohaa for the rest of the week. An independent research assistant will monitor the intervention process from the platform. If the corresponding dialogue is not completed on time each week, the participant will be reminded via WeChat to complete this session before the start of the next session in the following week.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: group ACT
Description: A 6-week group ACT intervention. Each group has 6-10 participants. Each session is one hour.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: wailist (delayed intervenion)
Description: During the intervention period, participants in the WLG were only required to complete the appropriate assessments without receiving any intervention. Upon completion of the 15-day follow-up assessment, participants in the WLG could be free to choose to receive one of the two interventions. The intervention will be the same as the corresponding experimental group.
Study: NCT06734091

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PrestoCHILL
Description: PrestoCHILL (Milestone Medical Technologies, Inc.MI 49009, USA)which by reducing the tissue freezing time to less than 60 seconds should eliminate freezing artefacts and improve the quality of sections for morphological and IHC examination. In selected cases and according to the diagnostic algorithm required for the diagnosis of specific neoplasms, rapid IHC analysis will be performed with the Benchmark ULTRA® immunostainer (Ventana Medical Systems), which is already in place to confirm or exclude the suspected neoplasm, as well as to confirm the histotype. For the latter purpose, commercially available antibody panels for routine examinations will be used (Ventana/Roche,Ventana Medical Systems, USA).